Skip to search formSkip to main contentSkip to account menu

palbociclib 100 MG Oral Capsule [Ibrance]

Known as: Ibrance 100 MG Oral Capsule 
National Institutes of Health

Related topics

Related topics

16 relations
AmmoniaGelatinLactose MonohydrateMagnesium stearate

Broader (1)

palbociclib 100 MG Oral Capsule

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
HR+/HER2- Mammakarzinom: Hohe Evidenz für Palbociclib im Langzeitverlauf
— Die endokrinbasierte Kombinationstherapie mit CDK4/6-Inhibitoren ist ein Standard für die Erstlinientherapie des Hormonrezeptor… 
2017
2017
Palbociclib (Ibrance®) in combination with fulvestrant for the treatment of hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer
As key cell cycle regulators, cyclin-dependent kinases 4 and 6 (CDK4/6) interact with cyclin D, to hyperphosphorylate… 
2016
2016
Is an Inhibitor or Blocker of Inactivation of Glycogen Synthase Kinase- 3β (GSK-3β) a Reliable Agent for Cancer Chemotherapy?
Is an Inhibitor or Blocker of Inactivation of Glycogen Synthase Kinase- 3β (GSK-3β) a Reliable Agent for Cancer Chemotherapy? 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)